ArticleCase reports in oncological medicine2026

Sustained Complete Response to Brigatinib in a Young Patient With ALK-Positive NSCLC Harboring I1171N Mutation Post-Alectinib Resistance.

Akhil Kapoor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.